MAP1LC3A and cancer: This interplay between RT, IFN-type-I response, LC3A-mediated autophagy, and HLA-class-I expression by cancer cells provides a promising target for the development of radio-vaccination strategies aiming to enhance the efficacy of radio-immunotherapy.